What We Do

ReaGenics is creating unique cannabinoid profiles, in stable laboratory controlled environments, by growing cannabis in a plant cell bio-reactor (PCBR). 

Who We Are

ReaGenics is an Israeli based company, with founders from Poland and Israel, bring the best IP to the most dynamic cannabis ecosystem. 

Contact

ReaGenics

SUBS hub, 5 Hauman Street

Beit Shemesh, Israel

Tel. +972 54 4405207

michael@reagenics.com

Problems with traditional cannabis cultivation

Expensive

Cost of machinery, facility, electricity, etc.

Difficult

Requires skilled workers

Time consuming

Whole plants take 6-12 weeks to flower

Unscalable

Yields are limited

Environmentally unsustainable

Uses large amounts of space and natural resources

Uncontrolled

Variations and contaminations in the environment make plants impossible to standardize

What’s the Solution?

Control all environmental factors by growing cannabis in a plant cell bio-reactor (PCBR)

About Our Technology

ReaGenics is pioneering a novel plant cell bioreactor process for the mass-scale multiplication of cannabinoids. This eliminates the need to grow plants on an industrial scale for pharma-grade, botanically- derived cannabinoids. Leveraging success with patented technology for multiplication and manipulation of lavender cells, ReaGenics is applying the same technology to cannabis, allowing for consistent, controllable, and patentable formulations.

diag

ReaGenics anticipates production periods up to four times faster and projected costs considerably cheaper, than plant cultivation. Creating powdered biomass for active pharmaceutical ingredients or extracted to produce cannabinoid oils, Bio-Reactor Production will change the way we look at medical cannabis.

Contact Us To Learn More:

About the team

ReaGenics is an Israeli based company, with founders from Poland and Israel, bringing the best IP to the most dynamic cannabis ecosystem.

 

Dr. Michael Kagan – CEO and co-founder of ReaGenics. Serial entrepreneur with 12 patents and 15 years experience growing micro-algae in bioreactors, clinical trials and FDA approvals.

Rafal Slusarczyk – VP R&D and co-founder of ReaGenics. Biologist specializing in environmental science with 10 years of experience as a technology transfer expert.

Prof. Danuta Kulpa – Chief Scientist – Professor at the West Pomeranian University of Technology, Szczecin, Poland specializing in plant genetics, plant breeding and biotechnology.

Saul Kaye – Co-founder and Chief Advisor – Pharmacist, angel investor, serial entrepreneur, cannabis expert.

Product Pipeline:

– 80% CBD Broad Spectrum Hemp extract

– Full spectrum Cannabis extract – high THC, low CBD

– Rare cannabinoids (e.g. THCV, CBG)

– Unique, cannabinoid-based formulation for Irritable Bowel Disease, developed in collaboration with The Hebrew University of Jerusalem

Award Winning!

Co-founder, Rafal Slusarczyk, won sponsorship from the European Union as a participant in the Erasmus for Young Entrepreneurs program. He is the first member of the program in Israel.
We are always on the lookout for investors and collaborators.

Blog

We invite you to read the latest information on current events .

Contact

Contact us to discover opportunities!

 

ReaGenics

SUBS hub, 5 Hauman Street

Beit Shemesh, Israel

Tel. +972 54 4405207

michael@reagenics.com